Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.64 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.47 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19725385 | 1.00 | TRPA1 (0.69) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL21852752 | 1.00 | TRPA1 (0.69) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL4951816 | 0.88 | TRPA1 (0.67) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL30934 | 0.87 | TRPA1 (0.77) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL1140503 | 0.84 | TRPA1 (0.74) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| Water SCHEMBL3896311 | 0.84 | TRPA1 (0.74) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL1396351 | 0.84 | CYP2D6 (0.69) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL21999232 | 0.84 | TRPA1 (0.62) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL3075876 | 0.84 | TRPA1 (0.62) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 | |
| SCHEMBL21581224 | 0.83 | TRPA1 (0.55) | TRPA1CYP2D6TAAR1SIGMAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 545 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| EP-4555060-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | The Procter & Gamble Company (US) | 2025-05-21 | — | — | EP | claimed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| EP-4516118-A2 | USE OF AMBOCENIDE® FOR REINFORCING A LILY OF THE VALLEY NOTE | Symrise AG (DE) | 2025-03-05 | — | — | EP | claimed |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| EP-3665163-B1 | USE OF AMBROCENIDE® FOR ENHANCING THE FRAGRANCE OF LILLIES OF THE VALLEY | SYMRISE AG (DE) | 2024-12-25 | — | — | EP | claimed |
| WO-2013053102-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-04-18 | — | — | WO | claimed |
| US-20100152083-A1 | Perfume Systems | PROCTER & GAMBLE COMPANY, THE | 2010-06-17 | — | — | US | claimed |
| EP-1888668-B1 | ALCOHOL ODOROUS SUBSTANCE-RELEASING POLYSILOXANE | EVONIK DEGUSSA GMBH (DE) | 2008-09-10 | — | — | EP | claimed |
| WO-2008068059-A2 | URINE-ABSORBING COMPOSITION WITH FRAGRANCE RELEASE UPON USE | EVONIK DEGUSSA GMBH (DE) | 2008-06-12 | — | — | WO | claimed |
| US-20080139378-A1 | Urine-absorbing composition with fragrance release upon use | DEGUSSA AG (DE) | 2008-06-12 | — | — | US | claimed |
| CN-101193950-A | Fragrance alcohol-releasing polysiloxane | DEGUSSA (DE) | 2008-06-04 | — | — | CN | claimed |
| EP-1888668-A1 | ALCOHOL ODOROUS SUBSTANCE-RELEASING POLYSILOXANE | Evonik Degussa GmbH (DE) | 2008-02-20 | — | — | EP | claimed |
| US-7229958-B2 | Fragrance alcohol-releasing polysiloxane | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | claimed |
| US-20070021319-A1 | Fragrance alcohol-releasing polysiloxane | DEGUSSA AG (DE) | 2007-01-25 | — | — | US | claimed |
| WO-2006131430-A1 | ALCOHOL ODOROUS SUBSTANCE-RELEASING POLYSILOXANE | EVONIK DEGUSSA GMBH (DE) | 2006-12-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | TRPA1 956/4885CYP2D6 3847/4885TAAR1 1199/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | TRPA1 1449/4885CYP2D6 3956/4885TAAR1 59/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | TRPA1 1897/4885CYP2D6 2139/4885TAAR1 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.